Find Clinical Trials

All CategoriesMedical Conditions»Eye Disorders»Ocular Motility Disorders



Join Paid Clinical Trials



  • Condition:   Convergence Insufficiency
    Intervention:   Behavioral: Office Based Vergence and Accommodative Therapy
    Sponsors:   New Jersey Institute of Technology;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Concussion;   Convergence Insufficiency
    Interventions:   Behavioral: Standard Community Concussion Care (SC);   Behavioral: SC plus Simple Convergence Procedures (SC+);   Behavioral: SC plus Office-based Vergence/Accommodative Therapy (SC+VAT)
    Sponsors:   Mitchell Scheiman;   Ohio State University;   University of Alabama at Birmingham;   Marshall B. Ketchum University;   Stanford University;   Children's Hospital Medical Center, Cincinnati;   Children's Hospital of Philadelphia;   Boston Children’s Hospital;   New Jersey Institute of Technology
    Not yet recruiting

  • Condition:   Convergence Insufficiency
    Intervention:   Procedure: office-based vergence/accommodative therapy
    Sponsor:   Salus University
    Recruiting

  • Conditions:   Concussion, Mild;   Convergence Insufficiency;   Accommodation; Insufficiency
    Intervention:   Device: Glasses
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Condition:   Strabismus
    Intervention:  
    Sponsors:   Royal Liverpool and Broadgreen University Hospitals NHS Trust;   Manchester University NHS Foundation Trust
    Recruiting

  • Condition:   Strabismus
    Intervention:   Other: EyeTurn App
    Sponsors:   Massachusetts Eye and Ear Infirmary;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Acquired Esotropia
    Interventions:   Drug: Botulinum toxin type A;   Procedure: Strabismus surgery
    Sponsor:   University Hospital Inselspital, Berne
    Recruiting

  • Condition:   Optokinetic Nystagmus
    Intervention:   Device: CAVA
    Sponsors:   Emily Woodhouse;   University of East Anglia;   Medical Research Council
    Recruiting

  • Condition:   Strabismus
    Intervention:   Other: Evaluate the reliability and reproductibility of the automated angular measurement by the Gazelab
    Sponsor:   Nantes University Hospital
    Not yet recruiting

  • Condition:   Horizontal Strabismus With High AC/A Ratio
    Interventions:   Procedure: conducting the slanted recession technique on the superior and inferior poles;   Procedure: conducting the augmented recession technique on the muscle
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Recruiting

  • Condition:   Strabismus
    Interventions:   Procedure: Symmetrical IO weakening;   Procedure: Asymmetrical IO weakening
    Sponsors:   Sultan Qaboos University;   Christian Medical College, Vellore, India
    Recruiting

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting

  • Conditions:   Mild Traumatic Brain Injury;   Brain Concussion;   Convergence Insufficiency;   Accommodative Insufficiency;   Saccadic Eye Movement Deficiency;   Oculomotor Dysfunction
    Intervention:  
    Sponsor:   Minneapolis Medical Research Foundation
    Recruiting

  • Conditions:   Anxiety;   Strabismus;   Compliance
    Intervention:  
    Sponsors:   Queen's University;   University of Regina
    Recruiting

  • Condition:   Exotropia
    Interventions:   Procedure: Plication strabismus surgery;   Procedure: Resection strabismus surgery
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Other: patch therapy
    Sponsor:   Tehran University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Device: Controlled Intermittent Alternate Occlusion (CIAO ) glasses
    Sponsor:   Salus University
    Recruiting

  • Condition:   Moderate Intermittent Exotropia
    Intervention:   Procedure: recession or resection of the horizontal extraocular muscles
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Parkinson Disease;   Parkinsonism;   Lewy Body Disease;   Supranuclear Palsy, Progressive;   Parkinsonism Vascular;   Multiple System Atrophy;   Corticobasal Degeneration
    Intervention:   Behavioral: Palliative Care
    Sponsors:   University of Colorado, Denver;   National Institute of Nursing Research (NINR);   University of California, San Francisco
    Recruiting

  • Conditions:   Progressive Supranuclear Palsy;   Dementia With Lewy Bodies;   Multiple System Atrophy;   Corticobasal Syndrome;   Atypical Parkinson Disease
    Interventions:   Behavioral: Home Visit Program;   Behavioral: Usual Care/Online Survey
    Sponsor:   Rush University Medical Center
    Recruiting

  • Conditions:   Frontotemporal Lobar Degeneration;   Amytrophic Lateral Sclerosis;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Device: 3D PD T1 MRI sequence
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Conditions:   Parkinson's Disease;   Parkinsonian Disorders;   Atypical Parkinson Disease;   Progressive Supranuclear Palsy;   Multiple System Atrophy;   Corticobasal Degeneration;   Gait, Frontal
    Interventions:   Drug: Anti-Parkinson medication;   Device: Deep Brain Stimulation
    Sponsor:   Beth Israel Deaconess Medical Center
    Recruiting

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Diagnostic Test: MRI T2 sequence of the oculomotor tract
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Conditions:   Healthy Volunteers;   Alzheimer Disease;   Progressive Supranuclear Palsy
    Intervention:   Drug: [18F]MNI-958
    Sponsor:   Invicro
    Recruiting

  • Conditions:   Alzheimer Disease (AD);   Frontotemporal Lobar Degeneration;   Dementia With Lewy Bodies (DLB);   Parkinson Disease Dementia (PDD);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
    Intervention:  
    Sponsors:   Amoneta Diagnostics SAS;   European Commission;   Firalis SA;   University Hospital, Strasbourg;   Centre Hospitalier Universitaire Vaudois;   IRCCS Centro San Giovanni di Dio Fatebenefratelli;   Hôpitaux Civils de Colmar;   Istanbul University;   Assistance Publique - Hôpitaux de Paris;   University Hospital, Lille;   University Hospital, Geneva;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain;   Erasme University Hospital;   University Hospital, Montpellier;   Centre Hospitalier Universitaire de Besancon;   Centre Hospitalier Universitaire de Nice
    Recruiting

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: Retinal Birefringence Imager
    Sponsors:   Rebiscan, Inc.;   Retina Foundation of the Southwest
    Not yet recruiting

  • Conditions:   Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Not yet recruiting

  • Conditions:   Macular Holes;   Epiretinal Membrane;   Diabetic Retinopathy;   Retinal Detachment;   Retinal Disease;   Preretinal Fibrosis;   Cataract;   Ocular Tumor;   Strabismus;   Healthy
    Intervention:   Device: Microscope integrated optical coherence tomography
    Sponsors:   Duke University;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Vascular Dementia;   Lewy Body Disease;   Lewy Body Dementia With Behavioral Disturbance (Disorder);   Dementia, Mixed;   Parkinson-Dementia Syndrome;   Chronic Traumatic Encephalopathy;   Huntington's Dementia;   Wernicke Korsakoff Syndrome;   Traumatic Brain Injury;   Dementia, Multi-Infarct;   Autism;   Autism Spectrum Disorder;   Autistic Behavior;   Autistic Disorder, Current or Active State;   Cadasil
    Interventions:   Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Near Infrared Light
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Neurologic Disorders;   Nervous System Diseases;   Neurodegenerative Diseases;   Neurological Disorders;   Stroke;   Traumatic Brain Injury;   Cadasil;   Chronic Traumatic Encephalopathy;   Cerebral Infarction;   Cerebral Ischemia;   Cerebral Stroke;   Cerebral Hemorrhage;   Parkinson;   Multi-System Degeneration;   MSA - Multiple System Atrophy;   Progressive Supranuclear Palsy;   ALS;   Amyotrophic Lateral Sclerosis;   Neuropathy;   Diabetic Neuropathies
    Interventions:   Procedure: Intravenous BMSC;   Procedure: Intranasal BMSC
    Sponsors:   MD Stem Cells;   The Healing Institute
    Recruiting

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting

  • Conditions:   Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Interventions:   Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
    Sponsor:   University Hospital, Bordeaux
    Recruiting

  • Conditions:   Strabismus;   Reflex, Oculocardiac;   Hydroxyzine;   Bradycardia Sinus
    Interventions:   Drug: Midazolam;   Drug: Hydroxyzine Dihydrochloride
    Sponsor:   Yeditepe University
    Recruiting

  • Conditions:   Humoral Rejection;   Guillain-Barre Syndrome;   Miller Fisher Syndrome;   CIDP;   Good Pasture Syndrome;   Hyperviscosity Syndrome
    Interventions:   Drug: Fibrinogen concentrate;   Other: Fresh Frozen Plasma
    Sponsor:   University Medical Centre Ljubljana
    Recruiting

  • Conditions:   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD);   Frontotemporal Dementia (FTD MAPT Mutation)
    Intervention:   Other: 13C6 Leucine
    Sponsors:   Washington University School of Medicine;   Association of Frontotemporal Degeneration;   Tau Consortium
    Recruiting

  • Condition:   Strabismus
    Intervention:  
    Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

  • Conditions:   Emergence Delirium;   Strabismus
    Intervention:   Drug: Methadone
    Sponsor:   Ochsner Health System
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Other: PSP-QoL
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Not yet recruiting

  • Conditions:   Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
    Intervention:   Other: Observational Study
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Conditions:   Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
    Intervention:   Drug: Amifampridine Phosphate
    Sponsor:   Catalyst Pharmaceuticals, Inc.
    Available

  • Condition:   Progressive Supranuclear Palsy (PSP)
    Intervention:   Drug: ABBV-8E12
    Sponsor:   AbbVie
    Recruiting

  • Conditions:   Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Rapid Eye Movement Sleep Behavior Disorder
    Intervention:  
    Sponsor:   The University of Texas Health Science Center, Houston
    Recruiting

  • Conditions:   Severe Mental Disorder;   Psychological Trauma
    Intervention:   Behavioral: Eye Movement Desensitization and Reprocessing (EMDR) Therapy
    Sponsors:   Parc de Salut Mar;   EMDR Europe;   Fundacion IMIM
    Recruiting

  • Condition:   Cerebellum Disease
    Interventions:   Behavioral: Forward adaptation of reactive saccades;   Behavioral: Backward adaptation of reactive saccades;   Behavioral: Execution of reactive saccades;   Behavioral: Generation of reactive saccades
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   REM Sleep Behavior Disorder;   Neurodegenerative Diseases
    Intervention:  
    Sponsor:   Chinese University of Hong Kong
    Recruiting

  • Condition:   Substance Use Disorders
    Interventions:   Other: EMDR;   Other: Treatment as Usual
    Sponsor:   Parc de Salut Mar
    Recruiting

  • Condition:   REM Sleep Behavior Disorder
    Interventions:   Drug: Melatonin 2mg;   Drug: ClonazePAM 0.5 MG
    Sponsor:   Kyung Hee University Hospital at Gangdong
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder;   Traumatic Brain Injury
    Intervention:   Behavioral: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) Therapy
    Sponsors:   Walter Reed National Military Medical Center;   Uniformed Services University of the Health Sciences
    Recruiting

  • Conditions:   Obstructive Sleep Apnea;   Diabetes Mellitus;   Coronary Artery Disease
    Intervention:  
    Sponsors:   National University, Singapore;   National Heart Centre Singapore
    Recruiting

Login to Get Started